UK/DE/US

Tender Offer of Deutsche Balaton Biotech AG

Tender Offer Deutsche Balaton Biotech AG

Deutsche Balaton Biotech AG, based in Frankfurt am Main, has submitted a public tender offer (“Offer”) to shareholders of Biofrontera AG to acquire up to 6,250,000 registered shares of Biofrontera AG with the ISIN DE0006046113.

Documents published by Deutsche Balaton Biotech AG regarding the Offer are available on the internet at https://www.deutschebalatonbiotech.de/erwerbsangebot-biofrontera. Biofrontera AG accepts no responsibility for such contents or other information available on this website.

 

According to Art. 27 of the German Securities Acquisition and Takeover Act (WpÜG), the Management Board and the Supervisory Board of Biofrontera AG are required to give an opinion on the Offer and any changes of the Offer.

Pursuant to Art. 27 WpÜG, employees also have the opportunity to give an opinion on the Offer.

Below you will find the opinion of the Biofrontera AG Management Board and Supervisory Board and any updates thereto, as well as the opinion of our employees:

Second opinion

  • Joint opinion Management Board and Supervisory Board (pdf)
  • Opinion of our employees (pdf)

 

First opinion

  • Joint opinion Management Board and Supervisory Board (pdf)
  • Opinion of our employees (pdf)